The global lancet and pen needles market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing prevalence of diabetes and obesity, which are major risk factors for chronic diseases such as cardiovascular disease, stroke, cancer, and diabetes mellitus type 2.The increasing number of patients with chronic diseases will drive the demand for lancets and pen needles in the coming years. The 17/18G segment accounted for over 50% share in 2017 owing to its low cost per needle unit (NPU) compared to other types such as 23G or 25G needles. This segment is expected to maintain its dominance throughout the forecast period due to its low cost per NPU compared with other types such as 23G or 25G needles.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is driving the growth of the market.
- Increasing awareness about the benefits of using pen needles for injections is also driving the growth of this market.
- The increasing number of hospitals in emerging economies such as China and India are also driving this market's growth.
- The introduction of new technologies in pen needles such as needle-free injection systems will provide opportunities for companies operating in this market.
Industry Growth Insights published a new data on “Lancet and Pen Needles Market”. The research report is titled “Lancet and Pen Needles Market research by Types (17/18G, 21G, 23G, 25G, 28G, 30G), By Applications (Clinics, Hospitals, Medical Institutions), By Players/Companies Becton, Dickinson and Company, Novo Nordisk, Ypsomed Holding AG, B. Braun Melsungen AG, HTL-Strefa S.A, Terumo Corporation, Artsana S.p.a, Owen Mumford Ltd, Allison Medical, Ultimed”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Lancet and Pen Needles Market Research Report
By Type
17/18G, 21G, 23G, 25G, 28G, 30G
By Application
Clinics, Hospitals, Medical Institutions
By Companies
Becton, Dickinson and Company, Novo Nordisk, Ypsomed Holding AG, B. Braun Melsungen AG, HTL-Strefa S.A, Terumo Corporation, Artsana S.p.a, Owen Mumford Ltd, Allison Medical, Ultimed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Lancet and Pen Needles Market Report Segments:
The global Lancet and Pen Needles market is segmented on the basis of:
Types
17/18G, 21G, 23G, 25G, 28G, 30G
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Medical Institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton
- Dickinson and Company
- Novo Nordisk
- Ypsomed Holding AG
- B. Braun Melsungen AG
- HTL-Strefa S.A
- Terumo Corporation
- Artsana S.p.a
- Owen Mumford Ltd
- Allison Medical
- Ultimed
Highlights of The Lancet and Pen Needles Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 17/18G
- 21G
- 23G
- 25G
- 28G
- 30G
- By Application:
- Clinics
- Hospitals
- Medical Institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lancet and Pen Needles Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lancet is a medical journal published by the London-based The Lancet Group. Pen needles are thin, sharp metal or plastic tubes used to inject medication into a patient's vein.
Some of the key players operating in the lancet and pen needles market are Becton, Dickinson and Company, Novo Nordisk, Ypsomed Holding AG, B. Braun Melsungen AG, HTL-Strefa S.A, Terumo Corporation, Artsana S.p.a, Owen Mumford Ltd, Allison Medical, Ultimed.
The lancet and pen needles market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lancet and Pen Needles Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Lancet and Pen Needles Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Lancet and Pen Needles Market - Supply Chain
4.5. Global Lancet and Pen Needles Market Forecast
4.5.1. Lancet and Pen Needles Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Lancet and Pen Needles Market Size (000 Units) and Y-o-Y Growth
4.5.3. Lancet and Pen Needles Market Absolute $ Opportunity
5. Global Lancet and Pen Needles Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Lancet and Pen Needles Market Size and Volume Forecast by Type
5.3.1. 17/18G
5.3.2. 21G
5.3.3. 23G
5.3.4. 25G
5.3.5. 28G
5.3.6. 30G
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Lancet and Pen Needles Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Lancet and Pen Needles Market Size and Volume Forecast by Application
6.3.1. Clinics
6.3.2. Hospitals
6.3.3. Medical Institutions
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Lancet and Pen Needles Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Lancet and Pen Needles Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Lancet and Pen Needles Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Lancet and Pen Needles Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Lancet and Pen Needles Demand Share Forecast, 2019-2026
9. North America Lancet and Pen Needles Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Lancet and Pen Needles Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Lancet and Pen Needles Market Size and Volume Forecast by Application
9.4.1. Clinics
9.4.2. Hospitals
9.4.3. Medical Institutions
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Lancet and Pen Needles Market Size and Volume Forecast by Type
9.7.1. 17/18G
9.7.2. 21G
9.7.3. 23G
9.7.4. 25G
9.7.5. 28G
9.7.6. 30G
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Lancet and Pen Needles Demand Share Forecast, 2019-2026
10. Latin America Lancet and Pen Needles Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Lancet and Pen Needles Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Lancet and Pen Needles Market Size and Volume Forecast by Application
10.4.1. Clinics
10.4.2. Hospitals
10.4.3. Medical Institutions
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Lancet and Pen Needles Market Size and Volume Forecast by Type
10.7.1. 17/18G
10.7.2. 21G
10.7.3. 23G
10.7.4. 25G
10.7.5. 28G
10.7.6. 30G
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Lancet and Pen Needles Demand Share Forecast, 2019-2026
11. Europe Lancet and Pen Needles Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Lancet and Pen Needles Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Lancet and Pen Needles Market Size and Volume Forecast by Application
11.4.1. Clinics
11.4.2. Hospitals
11.4.3. Medical Institutions
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Lancet and Pen Needles Market Size and Volume Forecast by Type
11.7.1. 17/18G
11.7.2. 21G
11.7.3. 23G
11.7.4. 25G
11.7.5. 28G
11.7.6. 30G
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Lancet and Pen Needles Demand Share, 2019-2026
12. Asia Pacific Lancet and Pen Needles Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Lancet and Pen Needles Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Lancet and Pen Needles Market Size and Volume Forecast by Application
12.4.1. Clinics
12.4.2. Hospitals
12.4.3. Medical Institutions
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Lancet and Pen Needles Market Size and Volume Forecast by Type
12.7.1. 17/18G
12.7.2. 21G
12.7.3. 23G
12.7.4. 25G
12.7.5. 28G
12.7.6. 30G
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Lancet and Pen Needles Demand Share, 2019-2026
13. Middle East & Africa Lancet and Pen Needles Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Lancet and Pen Needles Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Lancet and Pen Needles Market Size and Volume Forecast by Application
13.4.1. Clinics
13.4.2. Hospitals
13.4.3. Medical Institutions
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Lancet and Pen Needles Market Size and Volume Forecast by Type
13.7.1. 17/18G
13.7.2. 21G
13.7.3. 23G
13.7.4. 25G
13.7.5. 28G
13.7.6. 30G
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Lancet and Pen Needles Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Lancet and Pen Needles Market: Market Share Analysis
14.2. Lancet and Pen Needles Distributors and Customers
14.3. Lancet and Pen Needles Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Becton
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Dickinson and Company
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novo Nordisk
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Ypsomed Holding AG
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. B. Braun Melsungen AG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. HTL-Strefa S.A
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Terumo Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Artsana S.p.a
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Owen Mumford Ltd
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Allison Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ultimed
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook